Delivery Order SPE2DB22D1106-SPE2DB24FFGU0

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,295.74 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. This contract, which has an ultimate completion date of August 22, 2024, is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $4,526.20 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML autoinjectors. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,357.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp. for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that enables DLA to efficiently procure a comprehensive range of medical commodities to support military healthcare programs and facilities worldwide. The contract has no...
The U.S. Defense Logistics Agency (DLA) awarded a $8,761.90 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of AIMOVIG 70 MG/ML autoinjectors, with a period of performance ending on August 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a $8,465.56 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $8,465.56 and an ultimate completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and healthcare programs. This award is part of a...
The Defense Logistics Agency (DLA) awarded a $1,651.83 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division to provide AIMOVIG 140 MG/ML autoinjectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,796.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 70 mg/ml autoinjectors. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $1,140.48 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML autoinjectors. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for...
The U.S. government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $3,134.10 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently procure a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR. The $3,160.35 delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFGU0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,715.72 delivery order contract to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract has a firm fixed-price pricing structure and an ultimate completion date of August 15, 2024. There is no set-aside designation associated with this award.

Generated 11/13/24, 9:25 AM